These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14261243)

  • 1. BLOOD FATS AND THE CORONARY ARTERIES.
    WEITZMAN D
    Geriatrics; 1965 Mar; 20():172-8. PubMed ID: 14261243
    [No Abstract]   [Full Text] [Related]  

  • 2. 20, 25-DIAZACHOLESTENOL DIHYDROCHLORIDE. INHIBITION OF CHOLESTEROL BIOSYNTHESIS IN HYPERLIPEMIC SUBJECTS.
    SACHS BA; WOLFMAN L
    Arch Intern Med; 1965 Sep; 116():366-72. PubMed ID: 14325910
    [No Abstract]   [Full Text] [Related]  

  • 3. Control of serum lipids by diet and triparanol (MER 29).
    WILLIAMS GE; GADDIE R; SINGH SP
    J Atheroscler Res; 1962; 2():96-103. PubMed ID: 14007156
    [No Abstract]   [Full Text] [Related]  

  • 4. THE INFLUENCE OF NUTRITIONAL AND PHARMACOLOGICAL FACTORS ON THE BLOOD LIPID PATTERN IN ATHEROSCLEROTIC DISEASE AND IN THE TREATMENT OF PEPTIC ULCER.
    VERDONK G
    Bibl Nutr Dieta; 1964; 6():106-38. PubMed ID: 14247430
    [No Abstract]   [Full Text] [Related]  

  • 5. [Action of triparanol on blood lipid changes].
    MARCHESE G
    G Gerontol; 1962 May; 10():449-61. PubMed ID: 14469633
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of triparanol on serum low-density lipoproteins and cholesterol.
    ENGELBERG H
    Geriatrics; 1962 Aug; 17():528-31. PubMed ID: 13890232
    [No Abstract]   [Full Text] [Related]  

  • 7. Serum beta-lipoprotein lipids and protein during administration of Triparanol.
    CRAMER K
    Acta Med Scand; 1962 Apr; 171():435-9. PubMed ID: 13882000
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of triparanol (MER-29) in subjects with and without coronary artery disease.
    HOLLANDER W; CHOBANIAN AV; WILKINS RW
    JAMA; 1960 Sep; 174():5-12. PubMed ID: 13852511
    [No Abstract]   [Full Text] [Related]  

  • 9. CORONARY ARTERY DISEASE WITH SPECIAL REFERENCE TO THE EFFECTS OF CHOLESTEROL-LOWERING AGENTS.
    HERRMANN GR
    Med Bull (Ann Arbor); 1964; 30():12-8. PubMed ID: 14170885
    [No Abstract]   [Full Text] [Related]  

  • 10. Triparanol and nicotinic acid in the management of hypercholesterolaemia.
    DOAK PB; NICHOLSON GI; NORTH JD
    Australas Ann Med; 1962 Feb; 11():29-33. PubMed ID: 13886730
    [No Abstract]   [Full Text] [Related]  

  • 11. HYPERCHOLESTEROLEMIA IN CHICKS INJECTED WITH BETA-ESTRADIOL.
    WHITESIDE CH; FLUCKIGER HB; LONGENECKER JB; BARBORIAK JJ; SARETT HP
    J Atheroscler Res; 1965; 5(1):1-8. PubMed ID: 14253389
    [No Abstract]   [Full Text] [Related]  

  • 12. AN UNUSUAL SERUM LIPOPROTEIN-GLOBULIN COMPLEX IN A PATIENT WITH HYPERLIPEMIA.
    LEWIS LA; PAGE IH
    Am J Med; 1965 Feb; 38():286-97. PubMed ID: 14256725
    [No Abstract]   [Full Text] [Related]  

  • 13. THE EFFECT OF TRIPARANOL AND OF HEPARINOID ON SPONTANEOUS ATHEROSCLEROSIS OF HENS.
    MALINOW MR; MARINI MA; LEMA B; NEBBIA M; BERARDI JA
    Acta Physiol Lat Am; 1964; 14():71-6. PubMed ID: 14175168
    [No Abstract]   [Full Text] [Related]  

  • 14. Regression of coronary atheromatosis in rhesus monkeys.
    Armstrong ML; Warner ED; Connor WE
    Circ Res; 1970 Jul; 27(1):59-67. PubMed ID: 4987450
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapy and prevention of arteriosclerosis].
    Gerö S
    Z Alternsforsch; 1971; 24(4):301-20. PubMed ID: 4110936
    [No Abstract]   [Full Text] [Related]  

  • 16. TRIPARANOL (MER-29) IN HYPERCHOLESTEROLAEMIA: A DOUBLE-BLIND STUDY.
    FITZGERALD O; HEFFERNAN A; BRENNAN P; MULCAHY R
    J Ir Med Assoc; 1963 Oct; 53():116-20. PubMed ID: 14046560
    [No Abstract]   [Full Text] [Related]  

  • 17. THE EFFECT OF CHLOROPHENOXYISOBUTYRIC ACID AND ETHINYL ESTRADIOL ON CHOLESTEROL TURNOVER.
    NESTEL PJ; HIRSCH EZ; COUZENS EA
    J Clin Invest; 1965 Jun; 44(6):891-6. PubMed ID: 14322022
    [No Abstract]   [Full Text] [Related]  

  • 18. Triparanol therapy in coronary heart disease. A preliminary report.
    DAVIS FW
    Md State Med J; 1962 Apr; 11():178-81. PubMed ID: 13883898
    [No Abstract]   [Full Text] [Related]  

  • 19. Measures to reduce the serum lipid levels in coronary heart disease.
    Connor WE
    Med Clin North Am; 1968 Sep; 52(5):1249-60. PubMed ID: 4876837
    [No Abstract]   [Full Text] [Related]  

  • 20. The cholesterol lowering effects of triparanol (MER-29) in subjects with and without coronary artery disease.
    HOLLANDER W; CHOBANIAN AV; WILKINS RW
    Prog Cardiovasc Dis; 1960 May; 2():637-44. PubMed ID: 13852510
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.